A phase II, randomized, double-blind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: A Gynecologic Oncology Group partners study
Saved in:
Published in | Gynecologic oncology Vol. 145; pp. 220 - 221 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 0090-8258 |
---|---|
DOI: | 10.1016/j.ygyno.2017.03.507 |